Taken together, these findings show that the development of elevated SARS-CoV-2 spike gene diversity in PWH with CD4 counts < 200 cells/μL encompasses 1) high early diversity, beginning shortly after COVID-19 symptom onset, and 2) marked changes in the population of sequences detected in each person over time. The gene discussed is CD4; the disease is COVID-19.